Insider Transactions in Q2 2024 at Acelrx Pharmaceuticals Inc (ACRX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Marina Bozilenko |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+31.26%
|
-
|
|
Jun 24
2024
|
Abhinav Jain |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+41.66%
|
-
|
|
Jun 24
2024
|
Jill Marie Broadfoot |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+33.68%
|
-
|
|
Jun 24
2024
|
Adrian Adams |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+14.01%
|
-
|
|
Jun 24
2024
|
Stephen J Hoffman |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+32.13%
|
-
|
|
Jun 24
2024
|
Mark A Wan |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+32.13%
|
-
|
|
Jun 14
2024
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
1,304
+0.72%
|
$1,304
$1.08 P/Share
|
|
Jun 13
2024
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
4,570
+2.48%
|
$0
$0.97 P/Share
|
|
Jun 12
2024
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
4,126
+2.3%
|
$0
$0.97 P/Share
|